BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 03/08/2011

FDA Proposes to Refuse Approval of Bromday Supplemental New Drug Application

The FDA is proposing to refuse approval of a supplemental new drug application for Bromday (bromfenac ophthalmic solution, 0.09%) in a 2.4 milliliter fill size, giving ISTA Pharmaceuticals an opportunity to request a hearing.

Source: Federal Register — Health and Human ServicesOpen original release →